Johnson & Johnson JNJ
Johnson & Johnson · NYSE · Pharmaceutical Preparations
$271.04+0.86%close on Oct. 28, 2026 · volume 6.3M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Sept. 2, 2026 | Timothy Schmid EVP, WW Chair, MedTech | Sold | 33,597 | $274.74 | $9.23 million |
| Aug. 17, 2026 | Jennifer L. Taubert EVP, WWC. Innovative Medicine | Sold | 15,000 | $263.36 | $3.95 million |
| Aug. 13, 2026 | Joaquin Duato CEO and Chairman of the Board, director | Sold | 123,291 | $261.17 $261.00-$262.00 | $32.20 million |
| Aug. 6, 2026 | Elizabeth Forminard EVP, Chief Legal Officer | Sold | 15,918 | $257.00 $255.93-$257.76 | $4.09 million |
| Aug. 5, 2026 | Joaquin Duato CEO and Chairman of the Board, director | Sold | 48,480 | $258.15 $258.06-$258.74 | $12.52 million |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 13 →Results of operations and financial condition · Financial statements and exhibits